The immediate response to severe shock in a canine model with a combination of hypertonic-hyperoncotic solution with naloxone

Shock

Volumn 26, Issue 4, 2006, Pages 379-385

  García Martínez, David ^a   Portilla De Buen, Eliseo ^a,d   Leal, Caridad ^a   Santillán, Patricio ^b   Muñiz, Jesús ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSIDAD DE COLIMA   (Mexico)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Dog; Hemorrhage; Hypertonic saline dextran; Hypovolemia; Opiate receptor antagonist

Indexed keywords

DEXTRAN; HEPARIN; HYPERTONIC SOLUTION; NALOXONE; PROPIONYLPROMAZINE; SODIUM CHLORIDE;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DISEASE SEVERITY; DOG; FEMORAL ARTERY; HEART INDEX; HEMORRHAGIC SHOCK; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; NONHUMAN; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; PERIPHERAL CIRCULATION; SINGLE DRUG DOSE; SPECIES COMPARISON; SPLENECTOMY; URINE CATHETER; URINE VOLUME; VASCULAR RESISTANCE;

ALBUMINS; ANIMALS; DOGS; HYPERTONIC SOLUTIONS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; SHOCK;

EID: 33748742275     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000226339.48033.8b     Document Type: Article

References (35)

1. Tisherman SA: Trauma fluid resuscitation in 2010. J Trauma 54:S231-S234, 2003.
2. Chiara O, Pelosi P, Brazzi L, Bottino N, Taccone P, Cimbanassi S, Segala M, Gattinoni L, Scalea T: Resuscitation from hemorrhagic shock: experimental model comparing saline, dextran, and hypertonic saline solutions. Crit Care Med 31:1915-1922, 2003.
3. Mazzoni MC, Borgström P, Intaglietta M, Arfors KE: Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 40:187-193, 1990.
4. Pascual JL, Khwaja KA, Chaudhury P, Christou NV: Hypertonic saline and the microcirculation. J Trauma 54:S133-S140, 2003.
5. McIntosh TK, Palter M, Grasberger R, Vezina R, Gerstein L, Yeston N, Egdahl RH: Endorphins in primate hemorrhagic shock: beneficial action of opiate antagonists. J Surg Res 40:265-275, 1986.
6. Duarte RR, Ali MM, Sayegh NY, et al.: Effects of naloxone infusion in patients with septic shock and renal failure: a limited experience. Am J Nephrol 12:431-436, 1992.
7. Risöe C, Hall C, Smiseth OA: Blood volume changes in liver and spleen during cardiogenic shock in dogs. Am J Physiol 261:H1763-H1768, 1991.
8. Norma Oficial Mexicana NOM-062-ZOO-1999. Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. Diario Official de la Federación: 1-55, 2001.
9. Kirk RW, Bistner SI: Tablas y cuadros., In Kirk RW, Bistner SI (eds.): Urgencias en Veterinaria (1). Barcelona, Spain: Salvat Editores, pp 469-547, 1980.
10. Pascual JL, Ferri LE, Seely AJE, Campisi G, Chaudhury P, Giannias B, Evans DC, Razek T, Michel RP, Christou NV: Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage. Ann Surg 236:634-642, 2002.
11. Sakai H, Hara H, Tsai AG, Tsuchida E, Johnson PC, Intaglietta M: Changes in resistance vessels during hemorrhagic shock and resuscitation in conscious hamster model. Am J Physiol 276:H563-H571, 1999.
12. Kreimeier U, Messmer K: Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand 46:625-638, 2002.
13. Peters WP, Johnson MW, Friedman PA, et al.: Pressor effect of naloxone in septic shock. Lancet 1:529-532, 1981.
14. Moon PF, Kramer GC: Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis. Crit Care Med 23:323-331, 1995. 3-31.
15. Benjamin E, Oropello JM, Abalos AM, Hannon EM, Wang JK, Fischer E, Iberti TJ: Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med 22:1616-1623, 1994.
16. Napolitano LM: Naloxone therapy in shock: the controversy continues. Crit Care Med 28:887-888, 2000.
17. Boeuf B, Poirier V, Gauvin F, Guerguerian AM, Roy R, Farrell CA, Lacroix J: Naloxone for shock. Cochrane Database Syst Rev: CD004443, 2005.
18. Filseth OM, Evgenov OV, Jenssen T, Johansen O, Bjertnaes LJ: Low doses of naloxone stabilize hemodynamics in awake sheep after exposure to endotoxin. Acta Anaesthesiol Scand 45:63, 2001.
19. Weber TP, Meissner A, Stypmann J, Hartlage MG, Van Aken H, Rolf N: Naloxone improves splanchnic perfusion in conscious dogs through effects on the central nervous system. Anesthesiology 96:438-441, 2002.
20. Wichmann MW, Zellweger R, Ayala A, Chaudry IH: Effect of naloxone on immune responses after hemorrhagic shock. Crit Care Med 28:184-189, 2000.
21. Grevert P, Goldstein A: Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proc Natl Acad Sci U S A 74:1291-1294, 1977.
22. Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, Levine JD: Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans. Neurosci Lett 351:5-8, 2003.
23. Van der Linden P, Schmartz D, Gilbart E, Engelman E, Vincent JL: Effects of propofol, etomidate, and pentobarbital on critical oxygen delivery. Crit Care Med 28:2492-2499, 2003.
24. Strøm J, Häggmark S, Reiz S, SLrensen MB: Cardiovascular effects of pentobarbital in pigs, and the lack of response to naloxone in pentobarbital induced circulatory failure. Acta Anaesthesiol Scand 31:413-416, 1987.
25. Takasu A, Carrillo P, Stezoski SW, Safar P, Tisherman SA: Mild or moderate hypothermia but not increased oxygen breathing prolongs survival during lethal uncontrolled hemorrhagic shock in rats with monitoring of visceral dysoxia. Crit Care Med 27:1557-1564, 1999.
26. Takasu A, Stezoski SW, Stezoski J, Safar P, Tisherman S: Mild or moderate hypothermia, but not increased oxygen breathing, increases long-term survival after uncontrolled hemorrhagic shock in rats. Crit Care Med 28:465-474, 2000.
27. Childs EW, Udobi KF, Hunter FA: Hypothermia reduces microvascular permeability and reactive oxygen species expression after hemorrhagic shock. 58:271-277, 2005.
28. Wu X, Stezoski J, Safar P, Bauer A, Tuerler A, Schwarz N, Kentner R, Behringer W, Kochanek PM, Tisherman SA: Mild hypothermia during hemorrhagic shock in rats improves survival without significant effects on inflammatory responses. Crit Care Med 31:195-202, 2003.
29. Guven H, Amanvermez R, Malazgirt Z, Kaya E, Doganay Z, Celik C, Ozkan K: Moderate hypothermia prevents brain stem oxidative stress injury after hemorrhagic shock. J Trauma 53:66-72, 2002.
30. Mizushima Y, Wang P, Cioffi WG, Bland KI, Chaudry IH: Should normothermia be restored and maintained during resuscitation after trauma and hemorrhage? J Trauma 48:58-65, 2000.
31. Wu X, Stezoski J, Safar P, Nozari A, Tisherman SA: After spontaneous hypothermia during hemorrhagic shock, continuing mild hypothermia (34-C) improves early but not late survival in rats. J Trauma 55:308-316, 2003.
32. Gagliardi JA, Prado NG, Marino JC, Lederer S, Ramos AO, Bertolasi CA: Exercise training and heparin pretreatment in patients with coronary artery disease. Am Heart J 132:946-951, 1996.
33. Tsai AG, Friesenecker B, McCarthy M, Sakai H, Intaglietta M: Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 275:H2170-H2180, 1998.
34. Stammers AH, Vang SN, Mejak BL, Rauch ED, Hock LM: Quantification of the effect of altering hematocrit and temperature on blood viscosity. J Extra Corpor Technol 33:61, 2001.
35. Svensén CH, Waldrop KS, Edsberg L, Hahn RG: Natriuresis and the extracellular volume expansion by hypertonic saline. J Surg Res 113:6-12, 2003.